| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 06/06/2007 | DE102005058166A1 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren Controlled matrix transdermal system with amine salts of the ACE inhibitor dicarboxylic acids |
| 06/06/2007 | CN1976938A Thienopyrazole derivative having PDE7 inhibitory activity |
| 06/06/2007 | CN1976917A Pyridine derivatives of alkyl oxindoles functioning as active substance against 5-HT7 receptor |
| 06/06/2007 | CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor |
| 06/06/2007 | CN1976904A Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors |
| 06/06/2007 | CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia |
| 06/06/2007 | CN1319965C 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides |
| 06/05/2007 | USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 06/05/2007 | USRE39679 Substituted heterocycle fused gamma-carbolines |
| 06/05/2007 | US7226938 Heterocyclic compounds |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 05/31/2007 | WO2007014851A3 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 05/31/2007 | WO2006056412A8 Process for pd-catalysed c-n coupling in specific solvent systems |
| 05/31/2007 | US20070123553 Aryl imidazoles and their use as anti-cancer agents |
| 05/31/2007 | US20070123549 platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070120113 Supramolecular structures and method for forming the same |
| 05/31/2007 | DE69133083C5 Behandlung und Vorbeugung von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten Treatment and prevention mediated by elevated lyso-PAF mirror mental disorders with PAF antagonists |
| 05/31/2007 | CA2630752A1 Method of modulating stress-activated protein kinase system |
| 05/30/2007 | EP1789421A1 Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 05/30/2007 | EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1117667B1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS |
| 05/30/2007 | CN1972950A Stereoselective method for the production of clopidogrel |
| 05/30/2007 | CN1972949A Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 05/30/2007 | CN1972938A 环状胺化合物 Cyclic amine compound |
| 05/30/2007 | CN1318429C Substitution thieno[3',2':5,6]-pyridino[4,3-d]-pyrimidine-4(3H)-ketone and preparation method |
| 05/30/2007 | CN1318428C Thiophenopyridine substituted acetyl hyarazine derivative |
| 05/30/2007 | CN1318424C Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/29/2007 | US7223766 Bi-cyclic pyrimidine inhibitors of TGFβ |
| 05/29/2007 | US7223752 Biphenyl vasopressin agonists |
| 05/24/2007 | WO2007058628A1 Heteroalkyl linked pyrimidine derivatives |
| 05/24/2007 | WO2007058627A1 Oxygen linked pyrimidine derivatives |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007057705A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr) |
| 05/24/2007 | WO2007035010A3 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus |
| 05/24/2007 | US20070117993 epoxidation of isopulegol with hydrogen peroxide in presence of a oxidation catalyst system containing sodium tungstate ( NaWO4.2H2O), sodium hydrogen sulfate, phosphoric or boric acid and methyltrioctylammonium chloride to produce isopulegol epoxide; high catalytic activity; chemical intermediate |
| 05/24/2007 | US20070117973 Chalcogen-containing fused polycyclic organic material and method for producing same |
| 05/24/2007 | US20070117889 Process for the direct preparation of pyrrolo[3,4-C]pyrroles |
| 05/24/2007 | US20070117837 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
| 05/24/2007 | CA2629455A1 Heteroalkyl linked pyrimidine derivatives |
| 05/24/2007 | CA2629443A1 Oxygen linked pyrimidine derivatives |
| 05/23/2007 | EP1786807A1 Heterocyclic antiviral compounds |
| 05/23/2007 | EP1786774A1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/23/2007 | CN1968955A Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 05/23/2007 | CN1968954A Thienopyridine derivative |
| 05/23/2007 | CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/22/2007 | US7220777 Lactam derivatives as antagonists for human 11cby receptors |
| 05/22/2007 | US7220757 Topically administering to the patient an antibacterially effective amount compounds such as N-(4,5-Dibromothien-2-ylmethyl)-N'-(1H-imidazo[4,5-b]pyridine-2-yl)-propane-1,3-diamine for therapy of bacterial infection |
| 05/22/2007 | US7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220748 Administering, to a patient in need of such treatment, an effective amount of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine or a salt thereof |
| 05/18/2007 | WO2007056155A1 Heterocyclic compounds as tyrosine kinase modulators |
| 05/18/2007 | WO2007056091A2 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof |
| 05/18/2007 | WO2007054750A2 Process for the preparation of olanzapine |
| 05/18/2007 | WO2007053869A2 Novel 2,2-dithiosubstituted furanose derivatives, method for the production and use thereof |
| 05/18/2007 | WO2007029037A3 Class iia histone deacetylase (hdac) substrate |
| 05/18/2007 | WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators |
| 05/18/2007 | CA2628260A1 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof |
| 05/18/2007 | CA2608726A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 05/17/2007 | US20070112152 Metallocene compounds |
| 05/16/2007 | EP1784409A2 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | CN1964998A Transition metal compound, ligand system, catalyst system and process for preparing polyolefins |
| 05/16/2007 | CN1964980A Polymerisable thieno not 3,2-b|thiophenes |
| 05/16/2007 | CN1962635A Indoles compound preparation method |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1315839C Benzothiophene [32-b] indole kind derivative, its preparation method and use |
| 05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315834C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217709 Tetracyclic benzamide derivatives and methods of use thereof |
| 05/10/2007 | WO2007052300A2 Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate |
| 05/10/2007 | WO2007052167A2 Stable composition for a pharmaceutical formulation containing olanzapine |
| 05/10/2007 | WO2007051596A1 Novel retinyl biotinates and use thereof |
| 05/10/2007 | WO2007025709A3 Organic compounds |
| 05/10/2007 | WO2007002701A3 Anti-inflammatory aryl nitrile compounds |
| 05/10/2007 | WO2006113875A3 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 05/10/2007 | US20070106082 4-(4-Hydroxy-phenyl)-2-methyl-1,2,3,3a,4,9b-hexahydro-cyclopenta[c]chromen-8-ol; estrogen receptor beta agonists; anticarcinogenic agent; prostate, testicular, ovarian, lung cancers, benign prostatic hyperplasia; cardiovascular diseases, neurodegenerative disorders, urinary incontinence, osteoporosis |
| 05/10/2007 | US20070105890 Novel condensed imidazole derivative |
| 05/10/2007 | US20070105889 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for therapy of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea |
| 05/10/2007 | US20070105851 Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis |
| 05/10/2007 | US20070105847 1,3-Dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 05/10/2007 | US20070105721 Vinylogous 4-Hpyrones and their use in promoting plant growth |
| 05/10/2007 | CA2626586A1 Stable composition for a pharmaceutical formulation containing olanzapine |
| 05/09/2007 | EP1781668A2 Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| 05/09/2007 | EP1781667A1 Benzothienopyridines for use as inhibitors of eg5 kinesin |
| 05/09/2007 | EP1781666A1 Improved process for making form i of olanzapine. |
| 05/09/2007 | EP1781665A2 Olanzapine salts and their conversion to olanzapine free base |
| 05/09/2007 | EP1781664A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 05/09/2007 | EP1781653A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
| 05/09/2007 | EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 05/09/2007 | EP1126855B1 Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons |
| 05/09/2007 | EP1036078B1 Thienopyrimidines |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214703 Compounds for modulators of chemokine activity |